Attention-deficit/hyperactivity disorder affects millions of children and adults in the United States, with diagnosis and treatment patterns continuing to shift as awareness improves and screening practices become more sensitive (Danielson et al., 2018; Kessler et al., 2006). For many families on the Main Line and in Delaware County, stimulant medications have provided meaningful relief — but a significant subset of patients either cannot tolerate stimulants, prefer a non-pharmacological approach, or continue to struggle with residual attention and executive function deficits despite medication. Neurofeedback therapy offers a rigorously studied, brain-based alternative that trains the neural networks underlying attention directly, with an evidence base spanning more than five decades of clinical and experimental research.
The Neuroscience of Attention and ADHD
ADHD is not a deficit of attention in the colloquial sense — it is, more precisely, a disorder of attentional regulation. Neuroimaging and electrophysiological research has consistently demonstrated that individuals with ADHD show differences in brainwave and attentional-network activity, including theta and beta activity patterns associated with cortical arousal and regulatory difficulties (Arns et al., 2014). The prefrontal cortex, which governs executive function, impulse control, and sustained attention, depends on a well-calibrated balance between slow-wave and fast-wave oscillations to function effectively.
This understanding forms the neurobiological foundation for neurofeedback as a treatment for ADD/ADHD in Villanova & Horsham, PA. Rather than supplementing or blocking neurotransmitters externally, neurofeedback teaches the brain’s own regulatory systems to shift their activity patterns in the direction of better attentional control. At Complete Mind Care in Villanova, PA, we use quantitative EEG (qEEG) assessment to map each patient’s brainwave patterns before beginning a neurofeedback protocol, ensuring that the training targets each individual’s specific neurophysiological profile rather than a generic template.
How Neurofeedback Training Works
During a neurofeedback session, sensors are placed on the scalp to record real-time brainwave activity. This activity is translated into a visual and auditory feedback display — often a video, game, or tone — that responds dynamically to the brain’s state. When the brain produces the targeted activity pattern, such as reducing excess theta and increasing beta in frontal regions when clinically indicated, the feedback signal rewards this state. Over repeated sessions, the brain learns to sustain the desired activity patterns more consistently through operant conditioning principles applied to neural oscillations.
Patients at our Villanova clinic typically complete neurofeedback sessions two to three times per week, with a full course often spanning 30 to 40 sessions depending on baseline findings and treatment goals. The process is entirely non-invasive, requires no medication, and produces no pain or significant discomfort. Parents accompanying children for neurofeedback often comment on the clinic’s calm, welcoming atmosphere — a reflection of the Main Line community environment we serve.
The Clinical Evidence for Neurofeedback in ADHD
A 2019 meta-analysis published in European Child & Adolescent Psychiatry examining randomized controlled studies found that neurofeedback was associated with sustained reductions in inattention and hyperactivity/impulsivity at follow-up, with outcomes varying by rating source and study design (Van Doren et al., 2019). Importantly, studies that employ blinded or probably blinded ratings tend to show more conservative effects than unblinded ratings, a finding that helps contextualize the evidence appropriately.
Professional and scientific discussion continues regarding the magnitude and durability of neurofeedback effects across different patient populations, protocols, and study designs. While ongoing debate remains in the literature, the clinical data supporting neurofeedback for ADHD represents one of the stronger evidence bases among non-pharmacological interventions in child and adult psychiatry (Arns et al., 2014; Van Doren et al., 2019). Results vary by individual, and our clinical team presents the evidence honestly and completely during the evaluation process. For a broader look at how objective testing informs our ADHD assessments, see our post on QbTest ADHD Assessment.
Neurofeedback for Adults With ADHD and Focus Concerns
While much of the published literature focuses on children with ADHD, neurofeedback is also applicable to adults experiencing attention, focus, and executive function challenges. Many adults on the Main Line and throughout Delaware County seek evaluation for the first time in adulthood, having managed undiagnosed ADHD through high intelligence, structured environments, and compensatory strategies that eventually reach their limits under the pressures of career, parenting, or complex professional demands.
At Complete Mind Care, we evaluate adults for ADHD with the same rigor applied to pediatric assessments, including consideration of comorbid anxiety, depression, and sleep disorders that frequently co-occur and complicate the clinical picture. Discuss with your provider whether neurofeedback, combined with or without medication management, psychotherapy, or cognitive enhancement strategies, represents the most appropriate approach for your specific presentation.
Addressing Practical Barriers on the Main Line
Two barriers we commonly address with families and adults considering neurofeedback in the Villanova and Main Line communities involve time commitment and expectations. Neurofeedback requires consistent, frequent sessions over a multi-week course to produce durable neurophysiological change — it is not a quick fix, and patients who begin expecting overnight results may become discouraged before meaningful gains are achieved. We dedicate significant time at the initial consultation to establishing a realistic timeline, identifying measurable goals, and helping families understand that the neurological learning process underlying neurofeedback is gradual by design.
A second barrier involves skepticism from other healthcare providers who may be unfamiliar with the current literature. We welcome collaborative care and are experienced in communicating with primary care physicians, pediatricians, and school-based support teams to ensure that neurofeedback is integrated appropriately within each patient’s broader care framework. Our background in brain-based therapies means we approach these conversations with clinical depth and evidence-based confidence.
Integration with Other Treatments at Complete Mind Care
For patients whose ADHD intersects with anxiety, mood dysregulation, or learning challenges, neurofeedback at our Villanova clinic can be integrated alongside professional psychotherapy services, medication management, or TMS for cognitive enhancement treatment. The individualized treatment plan approach we apply at Complete Mind Care recognizes that ADHD rarely exists in isolation, and that addressing the whole neuropsychological picture produces better functional outcomes than targeting a single symptom cluster in isolation. Remission is our mission — for ADHD, this means achieving the level of attentional regulation and executive function that allows patients to perform at their full capacity in school, work, and everyday life.
FAQ
What is neurofeedback and how does it differ from other ADHD treatments?
Neurofeedback is a brain-training approach that uses real-time EEG monitoring to teach the brain to regulate its own activity patterns. Unlike stimulant medications, which temporarily alter neurotransmitter availability, neurofeedback aims to create lasting changes in the brain’s electrical activity through repeated learning. It is non-invasive, requires no medication, and is suitable for patients who prefer or require a non-pharmacological approach.
How many neurofeedback sessions are typically needed for ADHD?
A standard neurofeedback course for ADHD typically involves 30 to 40 sessions, usually conducted two to three times per week. Individual variation exists based on the severity of the presenting symptoms, baseline qEEG findings, and concurrent treatments. Our clinical team reassesses progress regularly and communicates any recommended protocol adjustments throughout the course.
Is neurofeedback covered by insurance?
Insurance coverage for neurofeedback varies considerably by plan and state. Some plans cover neurofeedback when medical necessity is documented and the treatment is provided by a licensed clinician. Our team reviews coverage options with patients during the initial consultation and helps identify any reimbursement pathways available. We believe cost should not prevent patients from accessing effective, evidence-based care.
Can neurofeedback be used alongside ADHD medication?
Yes. Neurofeedback and ADHD medication are not mutually exclusive and are frequently used in combination, particularly during the initial phase of training. Some patients and families pursue neurofeedback with the goal of eventually reducing medication dependence as neurological changes consolidate — a goal our clinical team supports while monitoring carefully and adjusting the plan based on observed outcomes.
Is neurofeedback effective for adults, or is it mainly for children?
Neurofeedback is appropriate for both children and adults. While the largest published evidence base involves pediatric populations, studies in adults demonstrate similar neurophysiological mechanisms and meaningful clinical benefits for attention, focus, and executive function. Many adults on the Main Line who received a first-time ADHD diagnosis as adults have found neurofeedback a valuable component of their individualized treatment plan.
Key Takeaways
Neurofeedback trains brainwave patterns associated with attention and executive function using real-time EEG feedback — a non-invasive, non-medication approach.
qEEG-guided assessment allows our Villanova team to design individualized neurofeedback protocols based on each patient’s specific neurophysiological profile.
Published reviews and meta-analyses support neurofeedback as a studied non-pharmacological intervention for ADHD, while noting that effect sizes and durability vary across study designs.
Neurofeedback is appropriate for both children and adults and can be used alongside or as an alternative to ADHD medications.
A full course typically involves 30–40 sessions over several weeks; progress is monitored regularly and the protocol adjusted based on clinical response.
Medical Disclaimer: The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Results may vary. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether this treatment is appropriate for you.
Conclusion
For individuals and families on the Main Line and throughout Delaware County seeking a brain-based, evidence-grounded approach to ADHD and focus, neurofeedback at Complete Mind Care in Villanova offers a rigorously evaluated option within a comprehensive clinical framework. Our team brings decades of combined experience in brain-based therapies, and our qEEG-guided, individualized approach ensures that training is calibrated to each patient’s unique neurophysiology rather than a one-size-fits-all protocol. We welcome patients of all ages and clinical histories to schedule a consultation at 795 E Lancaster Ave, Suite 210, Villanova, PA 19085, or by calling 215-918-7939. Remission is our mission — and for ADHD, that mission means helping every patient achieve the focus and clarity they deserve.
References
Arns, M., Heinrich, H., & Strehl, U. (2014). Evaluation of neurofeedback in ADHD: The long and winding road. Biological Psychology, 95, 108–115. https://doi.org/10.1016/j.biopsycho.2013.11.013
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018). Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. Journal of Clinical Child & Adolescent Psychology, 47(2), 199–212. https://doi.org/10.1080/15374416.2017.1417860
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., Spencer, T., Ustun, T. B., Walters, E. E., & Zaslavsky, A. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163(4), 716–723. https://doi.org/10.1176/appi.ajp.163.4.716
Monastra, V. J., Lynn, S., Linden, M., Lubar, J. F., Gruzelier, J., & LaVaque, T. J. (2005). Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 30(2), 95–114. https://doi.org/10.1007/s10484-005-4305-x
Van Doren, J., Arns, M., Heinrich, H., Vollebregt, M. A., Strehl, U., & Loo, S. K. (2019). Sustained effects of neurofeedback in ADHD: A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 28(3), 293–305. https://doi.org/10.1007/s00787-018-1121-4